COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 1951: Articles 19501-19510  | Next

SARS-CoV-2/COVID-19 hospitalised patients in Switzerland: a prospective cohort profile
Thiabaud, A., Iten, A., Balmelli, C., Senn, L., Troillet, N., Widmer, A., Flury, D., Schreiber, P. W., Vazquez, M., Damonti, L., Buettcher, M., Vuichard-Gysin, D., Kuhm, C., Cusini, A., Riedel, T., Nussbaumer, Y., Gaudenz, R., Heininger, U., Berger, C., Zucol, F., Bernhard-Stirnemann, S., Corti, N., Zimmermann, P., Uka, A., Niederer-Loher, A., Gardiol, C., Roelens, M., Keiser, O.
10.1101/2020.12.10.20246884 — Posted: 2020-12-11
Assessing the Performance of COVID-19 Forecasting Models in the U.S.
Colonna, K. J., Evans, J. S.
10.1101/2020.12.09.20246157 — Posted: 2020-12-11
Clinical characteristics of critically ill patients with COVID-19
Carboni Bisso, I., Huespe, I., Lockhart, C., Masso, A., Gonzalez Anaya, J., Hornos, M., Famiglietti, R., Di Grazia, M., Coria, P., San Roman, E., Las Heras, M. J.
10.1101/2020.12.09.20246413 — Posted: 2020-12-11
High Frequency and Prevalence of Community-Based Asymptomatic SARS-CoV-2 Infection
Allan-Blitz, L., Turner, I., Hertlein, F., Klausner, J. D.
10.1101/2020.12.09.20246249 — Posted: 2020-12-11
COVID-19 Test Strategy to Guide Quarantine Interval in University Students
Kolesar, J. M., Gayheart, T., Poston, L., Monday, E., Forster, D., Belcher, E., Jaiswal, R., Turner, J. K., Arnett, D. K., Durbin, E. B., Monroe, J., Romanelli, F., Arnold, S. M., Weiss, H., DiPaola, R.
10.1101/2020.12.09.20246785 — Posted: 2020-12-11
SARS-CoV-2-specific humoral and cellular immunity in renal transplant and haemodialysis patients treated with convalescent plasma
Lindemann, M., Krawczyk, A., Dolff, S., Konik, M., Rohn, H., Platte, M., Thuemmler, L., Schwarzkopf, S., Schipper, L., Bormann, M., van de Sand, L., Breyer, M., Klump, H., Knop, D., Lenz, V., Temme, C., Dittmer, U., Horn, P. A., Witzke, O.
10.1101/2020.12.09.20239673 — Posted: 2020-12-11
Into the SARS-CoV-2 playgrounds: investigating the origins of the Belgian second wave, from an Antwerp perspective
Naesens, R., Heireman, L., Vandamme, S., Willems, P., Van Herendael, B., Verstrepen, W., De Schouwer, P., Bruynseels, P.
10.1101/2020.12.09.20246462 — Posted: 2020-12-11
Through The Back Door: Expiratory Accumulation of SARS-Cov-2 in the Olfactory Mucosa as Mechanism for CNS Penetration
Quadrio, M., Pipolo, C., Bulfamante, A. M., Schillaci, A., Banchetti, J., Castellani, L., Saibene, A. M., Felisati, G.
10.1101/2020.12.09.20242396 — Posted: 2020-12-11
Artificial intelligence-enabled analysis of UK and US public attitudes on Facebook and Twitter towards COVID-19 vaccinations
Hussain, A., Tahir, A., Hussain, Z., Sheikh, Z., Gogate, M., Dashtipour, K., Ali, A., Sheikh, A.
10.1101/2020.12.08.20246231 — Posted: 2020-12-11
Characterizing the Dynamic of COVID-19 with a New Epidemic Model: Susceptible-Exposed-Symptomatic-Asymptomatic-Active-Removed
Yi, G. Y., Hu, P., He, W.
10.1101/2020.12.08.20246264 — Posted: 2020-12-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).